January 26, 2022
Urologic oncologist makes his mark through robotic surgery program
Marc Bjurlin, DO, MSc, FACOS, specializes in minimally invasive techniques in cancer surgery and brings his expertise to the single port robotic surgery program.
Tag: Bladder Cancer Clinical Program
August 30, 2021
Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes
Tracy Rose, MD, MPH, Matthew Milowsky, MD, and colleagues report that the regimen reduced the invasiveness of the cancer in 56% of patients in a phase II clinical trial.
August 16, 2021
Experimental drug that boosts immunotherapy shows promise in bladder cancer study
William Kim, MD, and colleagues have published findings that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in laboratory models.
July 27, 2021
Patients with advanced bladder cancer could benefit from immunotherapy regardless of gene mutation status
Led by William Kim, MD, and colleagues, this research has important implications for patients who have not been offered immunotherapy because of their genetic profiles.
July 8, 2020
Patient a friend to others on bladder cancer journey
Over the years, Linda Willey has helped others going through cancer treatment. After treatment for her own cancer, she continues to connect with and support cancer patients.
April 6, 2020
Milowsky, Osterman published in the journal Cancer
Matthew Milowsky, MD, co-wrote an editorial on efforts to optimize a new precision medicine approach for treating metastatic urothelial carcinoma.
April 2, 2020
Cure: Electronic Cigarette Use and Risk of Bladder Cancer
March 17, 2020
Studying wearable devices to connect patients and doctors after surgery
Research led by Lixin Song, PhD, RN, FAAN, uses wearable technology to monitor colon and bladder cancer patients for complications when they’re home after surgery.
February 17, 2020
UroToday: Risk Stratification and Management of High-Risk Muscle-Invasive Urothelial Carcinoma: Subtyping of High-risk Muscle Invasive Urothelial Carcinoma
June 19, 2019
Doctor sets sights on bladder cancer breakthroughs
For Matthew Milowsky, MD, the George Gabriel and Frances Gable Villere Distinguished Professor of Bladder and Genitourinary Cancer Research, the why of genitourinary cancers is just as important to him as the how and what. As a former philosophy major, it’s natural that the questions behind these cancers are what drive the clinician and researcher to explore new methods to treat and care for patients.